On March 27, the U.S. Supreme Court heard oral argument in Amgen v. Sanofi, a closely watched case concerning the appropriate legal standard for patent law's enablement requirement.

That requirement is found in Title 35 of the U.S. Code, Section 112(a), which provides that a patent must describe the invention "in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains ... to make and use the same."

Originally published by Law360 - March 31, 2023.